Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis

Internal Medicine
Satoshi YoshijiHiroshi Seno

Abstract

Abatacept, a cytotoxic T lymphocyte antigen-4 immunoglobulin recombinant fusion protein, is an immunosuppressive agent indicated for rheumatoid arthritis. Although no significant increase in malignancy has been reported in abatacept-treated patients, whether or not abatacept accelerates tumor progression in specific cancer types remains unclear. We herein report a 66-year-old woman who showed unusually rapid progression of hepatocellular carcinoma following abatacept therapy for rheumatoid arthritis. Abatacept was speculated to have accelerated her hepatocellular carcinoma progression in the setting of her preexisting risk factors: autoimmune hepatitis and long-term methotrexate use. We propose close tumor surveillance be performed during abatacept therapy, especially for high-risk patients.

References

Oct 18, 2003·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masahiko KodaYasushi Horie
Jan 28, 2005·The New England Journal of Medicine·UNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Sep 16, 2005·The New England Journal of Medicine·Mark C GenoveseMaxime Dougados
Sep 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Evan J Lipson, Charles G Drake
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
Sep 17, 2013·Journal of the American Academy of Dermatology·Maria A CorcorranJay C Vary
Jun 11, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ian N Crispe
Sep 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Abhijeet Kumar, Dung T Le
Oct 31, 2014·Clinical Case Reports·Arianna DeiddaMaria Erminia Stochino
Nov 7, 2016·Journal of Hepatology·Austin G DuffyTim F Greten
Mar 7, 2017·Journal of Clinical Pharmacy and Therapeutics·D OlivoF Ursini

❮ Previous
Next ❯

Citations

Apr 12, 2021·La Revue de médecine interne·J LapoirieF Bonnet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Related Papers

Zeitschrift für Rheumatologie
M GaubitzDie Kommission Pharmakotherapie der DGRh
Nihon rinsho. Japanese journal of clinical medicine
Masayoshi Harigai
Zeitschrift für Rheumatologie
K KrügerKommission Pharmakotherapie der DGRh
© 2022 Meta ULC. All rights reserved